Adam Cohen broadly supports the Broadview investment team in its day-to-day operations, including identification and screening of new opportunities, due diligence, negotiation of deal structure, and portfolio company involvement.. Prior to joining Broadview, Adam was a strategy consultant at Health Advances, where he specialized in life sciences. with a focus on cardiovascular technologies. At Health Advances, Adam led engagements in investment opportunity due diligence for strategic and financial investors as well as in commercial strategy for a broad range of BioPharma and Medtech clients. Adam also brings cardiovascular device engineering experience from prior roles at CVRx and Cardiac Solutions LLC.. Adam earned a master’s degree in Biomedical Engineering from Duke University as well as undergraduate degrees in Engineering Science and Economics with High Distinction from the University of Virginia.
